Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory effect of vitamin D in type 2 diabetes
ChiCTR-IPR-16008304Phase 4Not yet recruiting
- Sponsor
- Gansu Provincial People's Hospital
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of vitamin d in type 2 diabetes mellitus (T2DM), Vitamin D deficiency (VDD) and diabetic glomerulosclerosis (2 arms), sponsored by Gansu Provincial People's Hospital. Primary endpoints: Hemoglobin A1c, UAER and 10 more. Planned start May 2016; status: not yet recruiting.
02
Drugs
vitamin d
03
Conditions
type 2 diabetes mellitus (T2DM)Vitamin D deficiency (VDD)diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR-IPR-16008304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008304.